149 related articles for article (PubMed ID: 31374282)
1. A stochastic individual-based model to explore the role of spatial interactions and antigen recognition in the immune response against solid tumours.
Macfarlane FR; Chaplain M; Lorenzi T
J Theor Biol; 2019 Nov; 480():43-55. PubMed ID: 31374282
[TBL] [Abstract][Full Text] [Related]
2. Modelling the Immune Response to Cancer: An Individual-Based Approach Accounting for the Difference in Movement Between Inactive and Activated T Cells.
Macfarlane FR; Lorenzi T; Chaplain MAJ
Bull Math Biol; 2018 Jun; 80(6):1539-1562. PubMed ID: 29536427
[TBL] [Abstract][Full Text] [Related]
3. Expression of tumour-specific antigens underlies cancer immunoediting.
DuPage M; Mazumdar C; Schmidt LM; Cheung AF; Jacks T
Nature; 2012 Feb; 482(7385):405-9. PubMed ID: 22318517
[TBL] [Abstract][Full Text] [Related]
4. Immune responses to tumour antigens: implications for antigen specific immunotherapy of cancer.
Jäger D; Jäger E; Knuth A
J Clin Pathol; 2001 Sep; 54(9):669-74. PubMed ID: 11533070
[TBL] [Abstract][Full Text] [Related]
5. Immunotherapy II: Antigens, receptors and costimulation.
Searle PF; Young LS
Cancer Metastasis Rev; 1996 Sep; 15(3):329-49. PubMed ID: 9034595
[TBL] [Abstract][Full Text] [Related]
6. Tumour-specific CD4 T cells eradicate melanoma via indirect recognition of tumour-derived antigen.
Shklovskaya E; Terry AM; Guy TV; Buckley A; Bolton HA; Zhu E; Holst J; Fazekas de St. Groth B
Immunol Cell Biol; 2016 Jul; 94(6):593-603. PubMed ID: 26837456
[TBL] [Abstract][Full Text] [Related]
7. Allogeneic IgG combined with dendritic cell stimuli induce antitumour T-cell immunity.
Carmi Y; Spitzer MH; Linde IL; Burt BM; Prestwood TR; Perlman N; Davidson MG; Kenkel JA; Segal E; Pusapati GV; Bhattacharya N; Engleman EG
Nature; 2015 May; 521(7550):99-104. PubMed ID: 25924063
[TBL] [Abstract][Full Text] [Related]
8. Specific immunotherapy of cancer in elderly patients.
Matzku S; Zöller M
Drugs Aging; 2001; 18(9):639-64. PubMed ID: 11599633
[TBL] [Abstract][Full Text] [Related]
9. [Dendritic cells and immune function in cancer].
Chaux P
Pathol Biol (Paris); 1995 Dec; 43(10):897-903. PubMed ID: 8786896
[TBL] [Abstract][Full Text] [Related]
10. Tumour secreted grp170 chaperones full-length protein substrates and induces an adaptive anti-tumour immune response in vivo.
Arnouk H; Zynda ER; Wang XY; Hylander BL; Manjili MH; Repasky EA; Subjeck JR; Latif Kazim A
Int J Hyperthermia; 2010; 26(4):366-75. PubMed ID: 20210603
[TBL] [Abstract][Full Text] [Related]
11. A mathematical model to study the impact of intra-tumour heterogeneity on anti-tumour CD8
Leschiera E; Lorenzi T; Shen S; Almeida L; Audebert C
J Theor Biol; 2022 Apr; 538():111028. PubMed ID: 35085535
[TBL] [Abstract][Full Text] [Related]
12. Antigen processing and immune regulation in the response to tumours.
Reeves E; James E
Immunology; 2017 Jan; 150(1):16-24. PubMed ID: 27658710
[TBL] [Abstract][Full Text] [Related]
13. IFN-γ is required for cytotoxic T cell-dependent cancer genome immunoediting.
Takeda K; Nakayama M; Hayakawa Y; Kojima Y; Ikeda H; Imai N; Ogasawara K; Okumura K; Thomas DM; Smyth MJ
Nat Commun; 2017 Feb; 8():14607. PubMed ID: 28233863
[TBL] [Abstract][Full Text] [Related]
14. Tumour immunology, vaccination and escape strategies.
García-Lora A; Algarra I; Collado A; Garrido F
Eur J Immunogenet; 2003 Jun; 30(3):177-83. PubMed ID: 12786993
[TBL] [Abstract][Full Text] [Related]
15. Angiostasis as a way to improve immunotherapy.
Griffioen AW; Vyth-Dreese FA
Thromb Haemost; 2009 Jun; 101(6):1025-31. PubMed ID: 19492143
[TBL] [Abstract][Full Text] [Related]
16. Targeting the tumour profile using broad spectrum chimaeric antigen receptor T-cells.
Navai SA; Ahmed N
Biochem Soc Trans; 2016 Apr; 44(2):391-6. PubMed ID: 27068945
[TBL] [Abstract][Full Text] [Related]
17. Immunosuppressive networks in the tumour environment and their therapeutic relevance.
Zou W
Nat Rev Cancer; 2005 Apr; 5(4):263-74. PubMed ID: 15776005
[TBL] [Abstract][Full Text] [Related]
18. A Hybrid Discrete-Continuum Modelling Approach to Explore the Impact of T-Cell Infiltration on Anti-tumour Immune Response.
Almeida L; Audebert C; Leschiera E; Lorenzi T
Bull Math Biol; 2022 Oct; 84(12):141. PubMed ID: 36315362
[TBL] [Abstract][Full Text] [Related]
19. Identification of tumour rejection antigens recognized by T lymphocytes.
Boon T; De Plaen E; Lurquin C; Van den Eynde B; van der Bruggen P; Traversari C; Amar-Costesec A; Van Pel A
Cancer Surv; 1992; 13():23-37. PubMed ID: 1423324
[TBL] [Abstract][Full Text] [Related]
20. Novel costimulators in the immune gene therapy of cancer.
Galea-Lauri J; Farzaneh F; Gäken J
Cancer Gene Ther; 1996; 3(3):202-14. PubMed ID: 8725885
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
